Coronary CTA Use in Emergency Department saves time and money

Reference: Goldstein JA, Chinnaiyan KM, Abidov A, et al. The CT-STAT (coronary computed tomographic angiography for systemic triage of acute chest pain patients to treatment) trial. J Am Coll Cardiol 2011; 58: 1414-22.

Using coronary computed tomographic angiography (CTA) as a screening tool for low-risk patients with chest pain in the emergency department achieves lower costs and faster diagnoses compared with myocardial perfusion imaging but does not sacrifice safety or accuracy, according to results of a randomized trial appearing in the September 27, 2011, issue of the Journal of the American College of Cardiology.

For the trial, researchers led by Gilbert L. Raff, MD, of William Beaumont Hospital (Royal Oak, MI), randomized 699 patients with low-risk acute chest pain (TIMI risk score ≤ 4; normal initial ECG and cardiac enzymes) to standard nuclear stress imaging or coronary CTA as an initial screen at 16 different emergency departments between June 2007 and November 2008.

Both groups had substantial portions of patients ruled out from having significant CAD (82.2% with CTA, 89.9% with nuclear stress imaging). In addition, 24 patients (6.7%) were referred for invasive coronary angiography after CTA, with 13 (3.6%) receiving subsequent revascularization (4 CABG, 9 PCI). After nuclear stress imaging, 21 patients (6.2%) went on to coronary angiography (P = 0.8 compared with CTA), with 8 (2.4%) subsequently receiving revascularization (8 PCI, 0 CABG; P = 0.34 compared with CTA with regard to total revascularizations). There were no CABG procedures in the stress imaging arm.

SOLACI.ORG

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...